Ellume to make more over-the-counter COVID-19 tests for and in U.S.
The Department of Defense today awarded Ellume USA $231.8 million to ramp up domestic production of its COVID-19 diagnostic test, the first test users can perform fully at home without a prescription. The agency expects the contract to increase daily domestic production of the test by 640,000 by December.
The contract also will procure 8.5 million of the tests for U.S. distribution. The Food and Drug Administration recently authorized emergency use of the test, which can detect the SARS-CoV-2 virus in a nasal swab sample and report the results via a smartphone app.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…